"Covid-19 hasn鈥檛 removed the need for contraceptives. People are still having sex 鈥 and either using or not using contraception. The virus doesn鈥檛 change that so we need to keep this work going."
Q1. A tricky one to kick off 鈥 can you describe the project in one sentence?
This project aims to look at the upstream interventions to encourage contraceptive use in adolescents in low- and middle-income countries. It鈥檚 trying to understand how they work and why some interventions are more effective than others.
Q2. And this is part of the CEDIL initiative 鈥 can you briefly cover what that is?
Yes 鈥 so CEDIL stands for the Centre for Excellence in Development Impact and Learning. The 鈥 but in summary, it was funded by DFID to support innovations in impact evaluations and evidence synthesis in international development. Projects range from being a year to 3 years or more, and there are currently 25 projects.
Q3. Before getting into the details, I鈥檓 interested to know what led to this work. Is it part of an ongoing stream of work 鈥 or was there a particular 鈥榚ureka鈥 moment?
It stems from my interest in applicability. When can research findings from one setting or context be useful in another setting? And why is there variation in the effectiveness of interventions?
Answering these involves a deep understanding on how an intervention works.
In recent years, I鈥檝e been talking about this issue of applicability and methods with Dylan Kneale from UCL. I鈥檇 come to the realisation that in order to understand if findings can be applied to a new setting, we need to understand how an intervention works, and taking that to a higher level, you need mid-range theory.
Then the CEDIL call came out, and one of the streams was about transferability. In essence, it was about mid-range theory and transferability 鈥 so I thought, 鈥業f I don鈥檛 apply for this, what am I doing? This is a call that鈥檚 speaking to me鈥.
Q4. Is this closely linked to implementation research?
The point is, we鈥檙e not looking at the activity itself, we鈥檙e looking at the higher level 鈥 why the activity works.
I鈥檇 say there鈥檚 three key things when trying to understand why an intervention works and why there鈥檚 a variation in effectiveness, aside from the content of the intervention. First, the context it鈥檚 being done in. Secondly, the implementation. And finally there鈥檚 how it is experienced.
The implementation and experience are going to be shaped by the content and the context 鈥 in fact they鈥檙e all interlinked in a way. You might get the exact same intervention being done in two places, but in one place the context is different - so it鈥檚 not being implemented. Or it might be being experienced differently in one setting so its not effective.
What we鈥檙e doing is looking at the mid-range theory, a slightly higher level.
And the example I always use to explain this is around bulling in schools (which, as a caveat, I know nothing about). But let鈥檚 assume that there鈥檚 an intervention to reduce bullying in schools, and the way this aims to work is to 鈥榠ncrease the self esteem of the students鈥. The mid-range theory is that increasing self-esteem leads to a reduction in bullying. But this can take different forms in different schools. In School-A, it might be that everyone is given a badge to wear that says: 鈥業鈥檓 great鈥. In School-B, the badges might not work and instead it might be that fist-bumps with the teacher work. But the point is, we鈥檙e not looking at the activity itself, we鈥檙e looking at the higher level 鈥 why the activity works.
So if we know that we need to boost-self esteem to reduce bulling, and we can do this via X, Y, or Z. What the actual activity is will vary depending on the context.
Q4. And what do we already know about use of contraceptives in adolescents. Why is this a priortity for research?
We know that reducing adolescent child-bearing is a global priority nd that contraception is one of the ways of doing this.
There is a lot of evidence on the effectiveness of interventions to increase the use of contraception. But they鈥檙e typically targeting the supply of contraception or the individual-level factors that shape behaviour 鈥 that鈥檚 knowledge, attitudes etc.
But there are also upstream factors that really shape contraceptive use. By upstream factors I mean gender equality, fertility norms, economic empowerment, and participation in education 鈥 particularly for adolescent girls. These things will influence individual attitudes towards and behaviours related to contraception and we need to know: How can we try and intervene and shape these?
I.e. How do we reduce gender inequalities? How do we shift fertility norms so that it鈥檚 not expected that adolescent girls have babies? And how do we increase economic empowerment and education (particularly for adolescent girls)?
And then if we do that, what effect will it have on contraceptive use and how do interventions achieve this? So that鈥檚 the gap we鈥檙e trying to fill, as we鈥檙e not sure how clear the evidence is there. We want to develop something that can be transferred to different settings.
Q5. Is there an unmet need for contraceptives in adolescents currently?
There鈥檚 less focus on how to increase desire to avoid, limit, space or delay childbearing. And much less work on trying to increase adolescents鈥 agency 鈥 the belief that they are in control.
So this is an interesting question. As we鈥檙e addressing more than just this. If you conceptualise contraceptive demand as having three parts:
- The desire to avoid, space, delay or limit childbearing
- The desire to use contraception
- Having agency to use family planning
Currently, a lot of the interventions try to change individuals鈥 attitudes, knowledge, and behaviour 鈥 focussing on the desire to use contraception. But there鈥檚 less focus on how to increase desire to avoid, limit, space or delay childbearing. And much less work on trying to increase adolescents鈥 agency 鈥 the belief that they are in control, that they are able to use family planning. Young people might feel that they鈥檙e not in a position to use contraception, that they need permission, and that they鈥檙e constrained. It might not even be on their radar that it鈥檚 an option for them because the social norms and their lack of empowerment mean they just expect to have babies.
So how does this link to mid-range theory? Because you might decide to address interventions at each of these three parts. Individualistic interventions focus on trying to tell adolescents about contraception, how to use them, and supplying contraception. Mid-range theory helps us understand how to develop effective interventions that address all of these parts.
One of the core MSc modules I teach, Foundations for Health Promotion, discusses this 鈥 that having knowledge itself doesn鈥檛 necessarily change behaviour. There are wider issues that shape people鈥檚 behaviours and it鈥檚 important to address these.
Q6. Can you talk through some of the specific upstream factors you aim to look at?
It鈥檚 things like inequalities, norms, empowerment.
So, for example, the interventions might be cash transfers to keep girls in schools for longer. Or savings and loans schemes for adolescents to give them economic empowerment. Or some kind of campaign to shift the norms around teenage pregnancy and encourage spacing between children etc.
Q8. From what I understand, this is an innovative new analysis method. What does it involve and why is it new?
The main analysis method is QCA, or Qualitative Comparitative Analysis. It鈥檚 not that new in itself, but it is new for development and has only started being used in health relatively recently. It鈥檚 a way of looking in-depth at a small number of cases to try and explore the different combinations of factors that can lead to interventions being effective or ineffective, or harmful. For us, those cases are intervention evaluations.
We鈥檙e also using another method called intervention component analysis. It鈥檚 a way of exploring the nuts and bolts of the intervention - what it involved, how it was delivered, implementation and those kind of things. These factors are usually poorly reported in trials in the published literature 鈥 those bits get squeezed out with journals鈥 restricted word counts. But it鈥檚 also a historical issue. Interventions began in medicine where there鈥檚 much less context, 鈥業 gave Drug A at Dose Y using Technique X and patient got better/didn鈥檛 get better鈥 鈥 the results are the most important bit.
But now we talk about this 鈥榖lack box鈥 of interventions where you don鈥檛 actually know what was going on. And we can make some assumptions but if you wanted to replicate that intervention, it鈥檚 quite tricky. So this method aims to pull out those nuances and the therories that underpinned the intervention: How it was implemented? What challenges might they have faced with implementation that might otherwise have been missed?
And it鈥檚 vital to understand what are the key things that are needed in order for an intervention to work. Often, interventions can be taken to a new place and won鈥檛 be implemented in the same way, or it鈥檚 experienced in a different way. These things all need unpicking as they鈥檙e generally neglected.
Q9. So in practice 鈥 what does this research look like day-to-day? What will you and the team be spending your time doing?
There could be a whole range of different ways that you reach the same outcome. Because that鈥檚 the nature of messy real life world.
QCA
For QCA, we鈥檒l look at a set of characteristics that will typically be related to the content of the intervention, its implementation, and/or its context. We鈥檒l have a long list and code everything dependent on whether that characteristic is present or absent, i.e. was the setting it took place in rural or not rural, was it a high intensity or low intensity intervention etc.
We start with a long list, then bring it down to a short list, we keep testing and refining until we find some clear combinations of factors that lead to interventions being effective, or being ineffective/harmful.
A great thing about QCA is that it recognises that there isn鈥檛 just one route to effectiveness (or ineffectiveness). It鈥檚 not simply that you have to do all of these steps, and if you miss one, you won鈥檛 get the outcome that you鈥檙e after. There could be a whole range of different ways that you reach the same outcome. Because that鈥檚 the nature of messy real life world.
And because QCA isn鈥檛 based on a large number of cases, or in our case intervention evaluations, we鈥檙e really able to get a good, detailed understanding of them. So we鈥檙e constantly reflecting back and making sure we鈥檙e aware of what we understand from those studies and that it makes sense.
ICA
With the intervention component analysis, we鈥檒l be looking at the whole paper in depth. Rather than just analysing methods and results, we鈥檒l analyse the introduction section to see if there are any insights into the theories and concepts that underpin the intervention. It might not be explicitly stated as 鈥淚ntervention X was based on theory Y鈥 but it may be there in the introduction. In the discussion, the authors might comment, sometimes in passing, as to implementation or process issues that might explain the effect or lack of effect, so we鈥檒l capture that.
Q9. And what are the benefits of doing this type of analysis?
It鈥檚 a great way to look at this number of cases. If you were doing something that was purely qualitative or anthropological, you鈥檇 have a much smaller number of cases that you鈥檇 look into in more depth. But that wouldn鈥檛 necessarily be representative.
On the flip side, if you鈥檙e looking at hundreds or thousands of cases you do some quantitative or statistical analysis. But you don鈥檛 understand each of the cases in depth. So you do the analysis but you don鈥檛 necessarily understand why things work or not.
It鈥檚 a good method of trying to understand this heterogeneity in effects. And not just looking at it from a purely quantitative perspective, but keeping the in-depth qualitative understanding in there.
Q10. If everything goes to plan, what do you hope you will have achieved in 5 years鈥 time?
In terms of family planning, I would like to think that there would be greater recognition of the importance of upstream factors and this would be part of the debate around contraceptives and thinking about these wider issues.
But in terms of the research more broadly, it would great to see people using these methods and them becoming more established standard methods.
Q11. How has Covid-19 impacted this project, and why is it vital that we don鈥檛 neglect areas of research like this in the pandemic?
Its vital because sexual and reproductive health issues still exist 鈥 Covid-19 hasn鈥檛 removed the need for contraceptives. People are still having sex 鈥 and either using or not using contraception. The virus doesn鈥檛 change that so we need to keep this work going.
Currently we鈥檙e looking at what research has already been done and then we鈥檒l narrow it down to one subset. Part of that will be consulting our advisory group and having in the back of our minds: 鈥榳hat sort of interventions could be relevant during the pandemic?鈥 We鈥檒l consider if there are certain digital aspects we could focus on more, for instance.
Q12 Finally 鈥 this project is a collaboration. Can you tell me more about your partners and their role?
I鈥檓 hoping it will be the first of many collaborations with all involved!
I鈥檓 working with the in Mozambique. Their aim is to broadly improve sexual and reproductive health with particular attention to sexually transmitted infections (STIs), cervical cancer, maternal and child health, family planning, contraception and gender-based violence.
I work with a team based there and the director is an LSHTM alumni. The team haven鈥檛 been involved in a systematic review or evidence synthesis before, so I鈥檓 helping to take them through the steps involved in a review. And we鈥檙e drawing on their hub of expertise and experience in research and providing services for adolescents around contraceptive services and broader sexual and reproductive health issues and rights.
Basically 鈥 they know their stuff and I鈥檓 really just there to take them through the steps of a review.
My hope is that they can then apply this learning to other areas of research and take it forward, and we can have future collaborations. I鈥檇 love it if in future they鈥檙e leading a research bid and they sub-contract me to help with some of the analysis 鈥 but very much with them leading.
And I already mentioned Dylan Kneale at UCL, who it is great to finally be working with on this issue. He鈥檚 helping with the methodological aspects and the actual QCA analysis.
I鈥檓 hoping it will be the first of many collaborations with all involved!
LSHTM's short courses provide opportunities to study specialised topics across a broad range of public and global health fields. From AMR to vaccines, travel medicine to clinical trials, and modelling to malaria, refresh your skills and join one of our short courses today.